Hyperaldosteronism in pregnancy

Therapeutic Advances in Cardiovascular Disease

Volumn 3, Issue 2, 2009, Pages 123-132

  Escher, Geneviève ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Aldosterone; CYP11B2; GRA; Mineralocorticoid receptor; Pregnancy

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; STEROID 11BETA MONOOXYGENASE;

BIOSYNTHESIS; ELECTROLYTE BALANCE; FEMALE; GENETICS; HUMAN; HYPERALDOSTERONISM; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ALDOSTERONE; FEMALE; HUMANS; HYPERALDOSTERONISM; PREGNANCY; PREGNANCY COMPLICATIONS; RENIN-ANGIOTENSIN SYSTEM; STEROID 11-BETA-HYDROXYLASE; WATER-ELECTROLYTE BALANCE;

EID: 66149139316     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944708100180     Document Type: Review

References (51)

1. Albiston, A.L., Smith, R.E., Obeyesekere, V.R. and Krozowski, Z.S. (1995) Cloning of the 11β-HSD type II enzyme from human kidney, Endocr Res 21: 399-409.
2. Assali, N.S. and Westersten, A. (1961) Regional flow-pressure relationship in response to angiotensin in the intact dog and sheep, Circ Res 9: 189-193.
3. Brand, E., Chatelain, N., Mulatero, P., Féry, I., Curnow, K., Jeunemaitre, X. et al. (1998) Structural analysis and evaluation of the aldosterone synthase gene in hypertension, Hypertension 32: 198-204.
4. Brown, M.A., Thou, S.T. and Whitworth, J.A. (1995) Stimulation of aldosterone by ACTH in normal and hypertensive pregnancy, Am J Hypertens 8: 260-267.
5. Chapman, A.B., Abraham, W.T., Zamudio, S., Coffin, C., Merouani, A., Young, D. et al. (1998) Temporal relationships between hormonal and hemodynamic changes in early human pregnancy, Kidney Int 54: 2056-2063.
6. Conn, J.W. (1955) Primary aldosteronism, J Lab Clin Med 45: 661-664.
7. Connell, J.M. and Davies, E. (2005) The new biology of aldosterone, J Endocrinol 186: 1-20.
8. Dave-Sharma, S., Wilson, R.C., Harbison, M.D., Newfield, R., Azar, M.R., Krozowski, Z.S. et al. (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess, J Clin Endocrinol Metab 83: 2244-2254.
9. Davies, E., Holloway, C.D., Ingram, M.C., Inglis, G.C., Friel, E.C. et al. (1999) Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2, Hypertension 33: 703-707.
10. Dluhy, R.G. and Lifton, R.P. (1999) Glucocorticoid- remediable aldosteronism, J Clin Endocrinol Metab 84: 4341-4344.
11. Funder, J.W. (2007) Why are mineralocorticoid receptors so nonselective ? Curr Hypertens Rep 9: 112-116.
12. Gallery, E.D. and Brown, M.A. (1987) Control of sodium excretion in human pregnancy, Am J Kidney Dis 9: 290-295.
13. Gallery, E.D., Hunyor, S.N. and Gyrory, A.Z. (1979) Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy, J Med 48: 593-602.
14. Gant, N.F., Daley, G.L., Chand, S., Whalley, P.J. and MacDonald, P.C. (1973) A study of angiotensin II pressor response throughout primigravid pregnancy, J Clin Invest 52: 2682-2689.
15. Geller, D.S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A. et al. (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy, Science 289: 119-123.
16. Goland, R.S., Wardlaw, S.L., Stark, R.I., Brown Jr, L.S. and Frantz, A.G. (1986) High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy, J Clin Endocrinol Metab 63: 1199-1203.
17. Jeunemaitre, X., Chatellier, G., Kreft-Jais, C., Charru, A., de Vries, C., Plouin, P.F. et al. (1987) Efficacy and tolerance of spironolactone in essential hypertension, Am J Cardiol 60: 820-825.
18. Kalenga, M.K., de Gasparo, M., Thomas, K. and de Hertogh, R. (1996) Down-regulation of angiotensin AT 1 receptor by progesterone in human placenta, J Clin Endocrinol Metab 81: 998-1002.
19. Kreze Jr, A., Kothaj, P., Dobáková, M. and Rohon, S. (1999) Primary aldosteronism caused by aldosterone-producing adenoma in pregnancy - complicated by EPH gestosis, Wien Klin Wochenschr 111: 855-857.
20. Krozowski, Z.S., Stewart, P.M., Obeyesekere, V.R., Li, K. and Ferrari, P. (1997) Mutations in the 11β-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth, Clin Exp Hypertens 19: 519-529.
21. Lee, I.H., Campbell, C.R., Cook, D.I. and Dinudom, A. (2008) Regulation of epithelial Na+ channels by aldosterone: role of Sgk1, Clin Exp Pharmacol Physiol 35: 235-241.
22. LeHoux, J.G., Dupuis, G. and Lefebvre, A. (2000) Regulation of CYP11B2 gene expression by protein kinase C, Endocr Res 26: 1027-1031.
23. Longo, L.D. (1983) Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control, Am J Physiol 245: R720-R729
24. Matsubara, M. (2000) Genetic determination of human essential hypertension, Tohoku J Exp Med 192: 19-33.
25. Miyahara, K., Kawamoto, T., Mitsuuchi, Y., Toda, K., Imura, H., Gordon, R.D. et al. (1992) The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity, Biochem Biophys Res Commun 189: 885-891.
26. Miyamori, I., Inaba, S., Hatakeyama, H., Taniguchi, N. and Takeda, Y. (2000) Idiopathic hyperaldosteronism: analysis of aldosterone synthase gene, Biomed Pharmacother 54: 77s-79s.
27. Mulatero, P., Schiavone, D., Fallo, F., Rabbia, F., Pilon, C., Chiandussi, L. et al. (2001) CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism, Hypertension 35: 694-698.
28. Mulatero, P., Veglio, F., Pilon, C., Rabbia, F., Zocchi, C., Limone, P. et al. (1998) Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene, J Clin Endocrinol Metab 83: 2573-2575.
29. Murakami, T., Watanabe Ogura, E., Tanaka, Y. and Yamamoto, M. (2000) High blood pressure lowered by pregnancy, Lancet 356: 1980.
30. Myles, K. and Funder, J.W. (1996) Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies, Am J Physiol 270: E601-E607
31. Neerhof, M.G., Shlossman, P.A., Poll, D.S., Ludomirsky, A. and Weiner, S. (1991) Idiopathic aldosteronism in pregnancy, Obstet Gynecol 78: 489-491.
32. New, M.I., Levine, L.S., Biglieri, E.G., Pareira, J. and Ulick, S. (1977) Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension, J Clin Endocrinol Metab 44: 924-933.
33. Oda, N., Takeda, Y., Zhu, A., Usukura, M., Yoneda, T., Takata, H. et al. (2006) Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism, Hypertens Res 29: 9-14.
34. Pirani, B.B., Campbell, D.M. and MacGillivray, I. (1973) Plasma volume in normal first pregnancy, J Obstet Gynaecol Br Commonw 80: 884-887.
35. Quinkler, M., Johanssen, S., Grossmann, C., Baöhr, V., Muller, M., Oelkers, W. et al. (1999) Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites, Clin Endocrinol Metab 84: 4165-4171.
36. Quinkler, M., Meyer, B., Oelkers, W. and Diederich, S. (2003) Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo, J Clin Endocrinol Metab 88: 3767-3772.
37. Rafestin-Oblin, M.E., Souque, A., Bocchi, B., Pinon, G., Fagart, J. and Vandewalle, A. (2003) The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related, Endocrinology 144: 528-533.
38. Roberts, J.M. and Cooper, D.W. (2001) Pathogenesis and genetics of pre-eclampsia, Lancet 357: 53-56.
39. Rossi, G.P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C. et al. (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients, J Am Coll Cardiol 48: 2293-2300.
40. Schoof, E., Girstl, M., Frobenius, W., Kirschbaum, M., Repp, R., Knerr, I. et al. (2001) Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation, Eur J Endocrinol 145: 187-192.
41. Shojaati, K., Causevic, M., Kadereit, B., Dick, B., Imobersteg, J., Schneider, H. et al. (2004) Evidence for compromised aldosterone synthase enzyme activity in preeclampsia, Kidney Int 66: 2322-2328.
42. So, A., Duffy, D.L., Gordon, R.D., Jeske, Y.W., Lin-Su, K., New, M.I. et al. (2005) Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity, Hypertens 23: 1477-1484.
43. Solomon, C.G., Thiet, M., Moore Jr, F. and Seely, E.W. (1996) Primary hyperaldosteronism in pregnancy, J Reprod Med 41: 255-258.
44. Stowasser, M., Gordon, R.D., Tunny, T.J., Klemm, S.A., Finn, W.L. and Krek, A.L. (1992) Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism, Clin Exp Pharmacol Physiol 19: 319.
45. Stowasser, M., Sharman, J., Leano, R., Gordon, R.D., Ward, G., Cowley, D. et al. (2005) Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I, J Clin Endocrinol Metab 90: 5070-5076.
46. Takeda, Y., Miyamori, I., Yoneda, T., Hatakeyama, H., Inaba, S., Furukawa, K. et al. (1996) Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin, J Clin Endocrinol Metab 81: 2797-2800.
47. Tamaki, S., Iwai, N., Tsujita, Y. and Kinoshita, M. (1999) Genetic polymorphism of CYP11B2 gene and hypertension in Japanese, Hypertension 33: 266-270.
48. Weissgerber, T.L. and Wolfe, L.A. (2006) Physiological adaptation in early human pregnancy: adaptation to balance maternal-fetal demands, Appl Physiol Nutr Metab 1: 1-11.
49. Wieacker, P., Alexopoulos, A., de Gregorio, G. and Breckwoldt, M. (1989) Pregnancy in Addison's disease, Dtsch Med Wochenschr 114: 1117-1120.
50. Wyckoff, J.A., Seely, E.W., Hurwitz, S., Anderson, B.F., Lifton, R.P. and Dluhy, R.G. (2000) Glucocorticoid-remediable aldosteronism and pregnancy, Hypertension 35: 668-672.
51. Yu, H., Lin, S., Zhang, Y. and Liu, G. (2008) Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors, J Hypertens 26: 251-256.